Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
113 Results for "
RGD
" in MedChemExpress (MCE) Product Catalog:
Products (113)
113 Results for "RGD" in MCE Product Catalog:
Cat. No.: HY-W782087A
CAS No.: 2649490-34-4
Cat. No.: HY-P3448S
Synonyms: CEND-1-13C6,15N2; iRGD-13C6,15N2; LSTA1-13C6,15N2
Research Areas:
Cat. No.: HY-P2635
CAS No.: 91575-25-6
Cat. No.: HY-P11384
CAS No.: 144161-76-2
Target:
Research Areas:
Cat. No.: HY-P3530
CAS No.: 111844-21-4
Cat. No.: HY-P0322A
Synonyms: EMD 56574 TFA
Target:
Research Areas:
Cat. No.: HY-157157
CAS No.: 2642327-44-2
Target:
Research Areas:
PAD4-IN-3 (compound 4B) is a PAD4 inhibitor with antitumor activity in vitro and in vivo. PAD4-IN-3 was covalently linked to RGD sequence peptide-modified chitosan (K-CRGDV), resulting in an enhanced oxidative stress-responsive nanoagent. K-CRGDV-PAD4-IN-3 can actively target tumors, inhibit PAD4 activity, block the formation of neutrophil extracellular traps (NETs), and improve the tumor immune microenvironment in response to the tumor microenvironment .
Cat. No.: HY-126039
CAS No.: 168157-33-3
Target:
Research Areas:
L-739758 is an antagonist for αIIbβ3 integrin (platelet glycoprotein IIb/IIIa). L-739758 acts as a peptidomimetic, binds to αIIbβ3 integrin by mimicking the interaction of the RGD (arginine-glycine-aspartic acid) motif, and is involved in the blood coagulation process. L-739758 inhibits platelet aggregation, and is used for thrombosis research .
Category:
Target:
Cat. No.: HY-126402
CAS No.: 120103-89-1
Arg-Gly-Asp (RGD) is a synthetic peptide corresponding to the cell adhesion sequence for the integrins αVβ1, αVβ3, αVβ5, αVβ6, αVβ8, α8β1, and α5β1. It is a component of radioligands and peptidomimetics that have been used in the study of integrin expression and activity in vivo.
Cat. No.: HY-P3448S1
Synonyms: CEND-1-13C2,15N; iRGD-13C2,15N; LSTA1-13C2,15N
Research Areas:
Cat. No.: HY-168943A
Cat. No.: HY-168943B
Cat. No.: HY-168943C
Cat. No.: HY-P11773
CAS No.: 1094848-94-8
Research Areas:
Cat. No.: HY-P11774
CAS No.: 1094848-99-3
Cat. No.: HY-P11416
CAS No.: 122207-62-9
Target:
Research Areas:
Cat. No.: HY-P74525
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: TGFBI; RGD-Containing Collagen-Associated Protein; Prev. CSD1; Beta Ig-H3; Prev. CSD2; RGD-CAP; Prev. CSD3; Transforming Growth Factor, Beta-Induced, 68kDa; Prev. LCD1; Transforming Growth Factor Beta-Induced 68kDa; BIGH3; Transforming Growth Factor Beta
Species:
Human
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
